Menu
Search
|

Menu

Close
X

Takeda Pharmaceutical Co Ltd 4502.T (Tokyo Stock Exchange)

4,407.00 JPY
-93.00 (-2.07%)
As of 1:00 AM EST
chart
Previous Close 4,500.00
Open 4,440.00
Volume 6,024,000
3m Avg Volume 4,748,665
Today’s High 4,450.00
Today’s Low 4,387.00
52 Week High 6,693.00
52 Week Low 4,203.00
Shares Outstanding (mil) 794.70
Market Capitalization (mil) 3,592,053.00
Forward P/E 25.34
Dividend (Yield %) 90.00 ( 3.98 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

Sell Hold Buy
1.70 Mean rating from 10 analysts

KEY STATS

Revenue (mm, JPY)
FY19
880,611
FY18
1,770,531
FY17
1,732,050
FY16
1,807,378
FY15
1,777,824
EPS (JPY)
FY19
160.966
FY18
237.491
FY17
146.104
FY16
101.109
FY15
-185.794
*Note: Units in Millions of Yen
**Note: Units in Yen

KEY RATIOS

Price to Earnings (TTM)
vs sector
25.34
29.53
Price to Sales (TTM)
vs sector
2.03
22.95
Price to Book (MRQ)
vs sector
1.64
4.15
Price to Cash Flow (TTM)
vs sector
11.35
20.94
Total Debt to Equity (MRQ)
vs sector
46.14
15.47
LT Debt to Equity (MRQ)
vs sector
40.57
11.13
Return on Investment (TTM)
vs sector
4.05
13.00
Return on Equity (TTM)
vs sector
6.62
14.69

EXECUTIVE LEADERSHIP

Masahiro Sakane
Independent Chairman of the Executive Board, Since 2017
Salary: --
Bonus: --
Christophe Weber
President, Chief Executive Officer, Representative Director, Since 2015
Salary: --
Bonus: --
Andrew Plump
Chief Medical & Scientific Officer, Director, Since 2015
Salary: --
Bonus: --
Masato Iwasaki
President of Japan Pharma Business Unit, Director, Since 2015
Salary: --
Bonus: --
Yasuhiko Yamanaka
Director, Since 2016
Salary: --
Bonus: --

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

4F, 2-1-1, Nihombashihon-cho
CHUO-KU   TKY   103-8668

Phone: +813.32782111

Takeda Pharmaceutical Company Limited is a Japan-based company engaged in the pharmaceutical business. The Ethical Pharmaceutical segment is engaged in the manufacture and sale of pharmaceutical products, such as therapeutic substances for diabetes, circulatory drugs, anticancer drugs, drugs for central neurological diseases, digestive system drugs, hormonal agents, osteoporosis drugs, antibiotic agents, allergy medications, vitamin drops and vaccines, among others. The Consumer Healthcare segment manufactures and sells general drugs and medicines, as well as quasi drugs. The Others segment is involved in the manufacture and sale of reagents, clinical diagnostics and chemical products.

SPONSORED STORIES